
Juno Therapeutics
North America, Washington, United States, Seattle
Description
Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.
Investor Profile
Juno Therapeutics has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Series Unknown rounds (top funding stages).
- Majority of deals are located in China, United States.
- Strong thematic focus on Biotechnology, Health Care, Oncology.
Stage Focus
- Series B (33%)
- Series A (33%)
- Series Unknown (33%)
Country Focus
- China (67%)
- United States (33%)
Industry Focus
- Biotechnology
- Health Care
- Oncology
- Therapeutics
- Genetics
- Medical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Juno Therapeutics frequently co-invest with?
What are some of recent deals done by Juno Therapeutics?
Find More Investors Like Juno Therapeutics
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides








